Literature DB >> 456407

Metabolism of a new synthetic progestagen, Org 2969, in female volunteers. Pharmacokinetics after an oral dose.

L Viinikka, O Ylikorkala, R Vihko, H P Wijnand, M Booij, F van der Veen.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 456407     DOI： 10.1007/bf00558439

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound.

Authors:  S O Skouby
Journal:  Contraception       Date:  1976-11       Impact factor: 3.375

2.  Ovulation inhibition by a new low-dose progestagen.

Authors:  L Viinikka; E Hirvonen; O Ylikorkala; S Nummi; P Virkkunen; T Ranta; U Alapiessa; R Vihko
Journal:  Contraception       Date:  1977-07       Impact factor: 3.375

3.  Metabolism of lynestrenol to norethisterone by liver homogenate.

Authors:  A Mazaheri; K Fotherby; J R Chapman
Journal:  J Endocrinol       Date:  1970-06       Impact factor: 4.286

4.  Plasma levels of d-norgestrel and sex hormone binding globulin during oral d-norgestrel medication immediately after delivery and legal abortion.

Authors:  S Nilsson; A Victor; K G Nygren
Journal:  Contraception       Date:  1977-01       Impact factor: 3.375

5.  Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women.

Authors:  M Hümpel; H Wendt; G Pommerenke; C Weiss; U Speck
Journal:  Contraception       Date:  1978-03       Impact factor: 3.375

6.  Radioimmunoassay of a new progestagen, Org 2969, and its metabolite.

Authors:  L Viinikka
Journal:  J Steroid Biochem       Date:  1978-10       Impact factor: 4.292

7.  Biological effects of a new and potent progestagen. A clinical study.

Authors:  L Viinikka; O Ylikorkala; S Nummi; P Virkkunen; T Ranta; U Alapiessa; R Vihko
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

8.  Relation between sex hormone binding globulin and D-norgestrel levels in plasma.

Authors:  A Victor; E Weiner; E D Johansson
Journal:  Acta Endocrinol (Copenh)       Date:  1977-10
  8 in total
  4 in total

1.  The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel.

Authors:  Tuomas Korhonen; Ari Tolonen; Jouko Uusitalo; Stefan Lundgren; Jorma Jalonen; Kari Laine
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

2.  Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa.

Authors:  S Madden; D J Back; C A Martin; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  Bioavailability and bioequivalence of etonogestrel from two oral formulations of desogestrel: Cerazette and Liseta.

Authors:  C J Timmer; N Srivastava; T O Dieben; A F Cohen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Oct-Dec       Impact factor: 2.569

4.  Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 μg) in Healthy Female Volunteers.

Authors:  María Ángeles Pena; Emilio Sanz; Silvia Francisco; Ainhara Alonso; Zurine Abajo; Izaskun Felipe; Jaume Pascual; Digna Tost; Sandra Bailac
Journal:  Sci Pharm       Date:  2012-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.